Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
HMG1 (high mobility group 1) is a ubiquitous and abundant chromatincomponent. However, HMG1 can be secreted by activated macrophagesand monocytes, and can act as a mediator of inflammation andendotoxic lethality. Here we document a role of extracellularHMG1 in cell migration. HMG1 (and its individual DNA-bindingdomains) stimulated migration of rat smooth muscle cells inchemotaxis, chemokinesis, and wound healing assays. HMG1 inducedrapid and transient changes of cell shape, and actin cytoskeletonreorganization leading to an elongated polarized morphologytypical of motile cells. These effects were inhibited by antibodiesdirected against the receptor of advanced glycation endproducts,indicating that the receptor of advanced glycation endproductsis the receptor mediating the HMG1-dependent migratory responses.Pertussis toxin and the mitogen-activated protein kinase kinaseinhibitor PD98059 also blocked HMG1-induced rat smooth musclecell migration, suggesting that a Gi/o protein and mitogen-activatedprotein kinases are required for the HMG1 signaling pathway.We also show that HMG1 can be released by damage or necrosisof a variety of cell types, including endothelial cells. Thus,HMG1 has all the hallmarks of a molecule that can promote atherosclerosisand restenosis after vascular damage.
atherosclerosis, chemotaxis, high mobility group 1, receptorof advanced glycation endproducts, smooth muscle cells
The editors suggest the following Related Resources on Science sites:
In Science Signaling
PERSPECTIVES
Michael Bustin (24 September 2002) Sci. STKE2002 (151), pe39.
[DOI: 10.1126/stke.2002.151.pe39] |Abstract »|Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
DEK Is a Poly(ADP-Ribose) Acceptor in Apoptosis and Mediates Resistance to Genotoxic Stress.
F. Kappes, J. Fahrer, M. S. Khodadoust, A. Tabbert, C. Strasser, N. Mor-Vaknin, M. Moreno-Villanueva, A. Burkle, D. M. Markovitz, and E. Ferrando-May (2008)
Mol. Cell. Biol.
28, 3245-3257
|Abstract »|Full Text »|PDF »
Parafibromin, a Component of the Human PAF Complex, Regulates Growth Factors and Is Required for Embryonic Development and Survival in Adult Mice.
P. Wang, M. R. Bowl, S. Bender, J. Peng, L. Farber, J. Chen, A. Ali, Z. Zhang, A. S. Alberts, R. V. Thakker, et al. (2008)
Mol. Cell. Biol.
28, 2930-2940
|Abstract »|Full Text »|PDF »
HMGB1 preconditioning: therapeutic application for a danger signal?.
J. R. Klune, T. R. Billiar, and A. Tsung (2008)
J. Leukoc. Biol.
83, 558-563
|Abstract »|Full Text »|PDF »
Sensing danger--Hsp72 and HMGB1 as candidate signals.
The microtubule-targeting agent CA4P regresses leukemic xenografts by disrupting interaction with vascular cells and mitochondrial-dependent cell death.
I. Petit, M. A. Karajannis, L. Vincent, L. Young, J. Butler, A. T. Hooper, K. Shido, H. Steller, D. J. Chaplin, E. Feldman, et al. (2008)
Blood
111, 1951-1961
|Abstract »|Full Text »|PDF »
The Role of Nitric Oxide and the Unfolded Protein Response in Cytokine-Induced -Cell Death.
K. T. Chambers, J. A. Unverferth, S. M. Weber, R. C. Wek, F. Urano, and J. A. Corbett (2008)
Diabetes
57, 124-132
|Abstract »|Full Text »|PDF »
HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling.
A. Tsung, J. R. Klune, X. Zhang, G. Jeyabalan, Z. Cao, X. Peng, D. B. Stolz, D. A. Geller, M. R. Rosengart, and T. R. Billiar (2007)
J. Exp. Med.
204, 2913-2923
|Abstract »|Full Text »|PDF »
Multiple Effects of High Mobility Group Box Protein 1 in Skeletal Muscle Regeneration.
R. De Mori, S. Straino, A. Di Carlo, A. Mangoni, G. Pompilio, R. Palumbo, M. E. Bianchi, M. C. Capogrossi, and A. Germani (2007)
Arterioscler. Thromb. Vasc. Biol.
27, 2377-2383
|Abstract »|Full Text »|PDF »
Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-{kappa}B activation.
R. Palumbo, B. G. Galvez, T. Pusterla, F. De Marchis, G. Cossu, K. B. Marcu, and M. E. Bianchi (2007)
J. Cell Biol.
179, 33-40
|Abstract »|Full Text »|PDF »
Stage-Specific Secretion of HMGB1 in Cartilage Regulates Endochondral Ossification.
N. Taniguchi, K. Yoshida, T. Ito, M. Tsuda, Y. Mishima, T. Furumatsu, L. Ronfani, K. Abeyama, K.-i. Kawahara, S. Komiya, et al. (2007)
Mol. Cell. Biol.
27, 5650-5663
|Abstract »|Full Text »|PDF »
The Anti-inflammatory Effects of Heat Shock Protein 72 Involve Inhibition of High-Mobility-Group Box 1 Release and Proinflammatory Function in Macrophages.
D. Tang, R. Kang, W. Xiao, H. Wang, S. K. Calderwood, and X. Xiao (2007)
J. Immunol.
179, 1236-1244
|Abstract »|Full Text »|PDF »
Post-translational Methylation of High Mobility Group Box 1 (HMGB1) Causes Its Cytoplasmic Localization in Neutrophils.
I. Ito, J. Fukazawa, and M. Yoshida (2007)
J. Biol. Chem.
282, 16336-16344
|Abstract »|Full Text »|PDF »
Nuclear Heat Shock Protein 72 as a Negative Regulator of Oxidative Stress (Hydrogen Peroxide)-Induced HMGB1 Cytoplasmic Translocation and Release.
D. Tang, R. Kang, W. Xiao, L. Jiang, M. Liu, Y. Shi, K. Wang, H. Wang, and X. Xiao (2007)
J. Immunol.
178, 7376-7384
|Abstract »|Full Text »|PDF »
Masquerader: High Mobility Group Box-1 and Cancer.
J. E. Ellerman, C. K. Brown, M. de Vera, H. J. Zeh, T. Billiar, A. Rubartelli, and M. T. Lotze (2007)
Clin. Cancer Res.
13, 2836-2848
|Abstract »|Full Text »|PDF »
High-Mobility Group Box 1 Activates Integrin-Dependent Homing of Endothelial Progenitor Cells.
E. Chavakis, A. Hain, M. Vinci, G. Carmona, M. E. Bianchi, P. Vajkoczy, A. M. Zeiher, T. Chavakis, and S. Dimmeler (2007)
Circ. Res.
100, 204-212
|Abstract »|Full Text »|PDF »
DAMPs, PAMPs and alarmins: all we need to know about danger.
High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin.
D. Yang, Q. Chen, H. Yang, K. J. Tracey, M. Bustin, and J. J. Oppenheim (2007)
J. Leukoc. Biol.
81, 59-66
|Abstract »|Full Text »|PDF »
Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice.
G. Sitia, M. Iannacone, S. Muller, M. E. Bianchi, and L. G. Guidotti (2007)
J. Leukoc. Biol.
81, 100-107
|Abstract »|Full Text »|PDF »
HMGB1-secreting capacity of multiple cell lineages revealed by a novel HMGB1 ELISPOT assay.
H. Wahamaa, T. Vallerskog, S. Qin, C. Lunderius, G. LaRosa, U. Andersson, and H. E. Harris (2007)
J. Leukoc. Biol.
81, 129-136
|Abstract »|Full Text »|PDF »
Increasing numbers of hepatic dendritic cells promote HMGB1-mediated ischemia-reperfusion injury.
A. Tsung, N. Zheng, G. Jeyabalan, K. Izuishi, J. R. Klune, D. A. Geller, M. T. Lotze, L. Lu, and T. R. Billiar (2007)
J. Leukoc. Biol.
81, 119-128
|Abstract »|Full Text »|PDF »
Nucleocytoplasmic Shuttling of HMGB1 Is Regulated by Phosphorylation That Redirects It toward Secretion.
Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein.
A. Porto, R. Palumbo, M. Pieroni, G. Aprigliano, R. Chiesa, F. Sanvito, A. Maseri, and M. E. Bianchi (2006)
FASEB J
20, 2565-2566
|Abstract »|Full Text »|PDF »
The high mobility group box chromosomal protein 1 is expressed in the human and rat testis where it may function as an antibacterial factor.
C. K. Zetterstrom, M.-L. Strand, and O. Soder (2006)
Hum. Reprod.
21, 2801-2809
|Abstract »|Full Text »|PDF »
Contribution of High-Mobility Group Box-1 to the Development of Ventilator-induced Lung Injury.
E. N. Ogawa, A. Ishizaka, S. Tasaka, H. Koh, H. Ueno, F. Amaya, M. Ebina, S. Yamada, Y. Funakoshi, J. Soejima, et al. (2006)
Am. J. Respir. Crit. Care Med.
174, 400-407
|Abstract »|Full Text »|PDF »
Activation of sPLA2-IIA and PGE2 production by high mobility group protein B1 in vascular smooth muscle cells sensitized by IL-1{beta}.
A. Jaulmes, S. Thierry, B. Janvier, M. Raymondjean, and V. Marechal (2006)
FASEB J
20, 1727-1729
|Abstract »|Full Text »|PDF »
Cutting Edge: High-Mobility Group Box 1 Preconditioning Protects against Liver Ischemia-Reperfusion Injury..
K. Izuishi, A. Tsung, G. Jeyabalan, N. D. Critchlow, J. Li, K. J. Tracey, R. A. Demarco, M. T. Lotze, M. P. Fink, D. A. Geller, et al. (2006)
J. Immunol.
176, 7154-7158
|Abstract »|Full Text »|PDF »
High mobility group box 1 protein interacts with multiple Toll-like receptors.
J. S. Park, F. Gamboni-Robertson, Q. He, D. Svetkauskaite, J.-Y. Kim, D. Strassheim, J.-W. Sohn, S. Yamada, I. Maruyama, A. Banerjee, et al. (2006)
Am J Physiol Cell Physiol
290, C917-C924
|Abstract »|Full Text »|PDF »
Cutting Edge: Extracellular High Mobility Group Box-1 Protein Is a Proangiogenic Cytokine.
S. Mitola, M. Belleri, C. Urbinati, D. Coltrini, B. Sparatore, M. Pedrazzi, E. Melloni, and M. Presta (2006)
J. Immunol.
176, 12-15
|Abstract »|Full Text »|PDF »
Exogenous High-Mobility Group Box 1 Protein Induces Myocardial Regeneration After Infarction via Enhanced Cardiac C-Kit+ Cell Proliferation and Differentiation.
F. Limana, A. Germani, A. Zacheo, J. Kajstura, A. Di Carlo, G. Borsellino, O. Leoni, R. Palumbo, L. Battistini, R. Rastaldo, et al. (2005)
Circ. Res.
97, e73-e83
|Abstract »|Full Text »|PDF »
Differential Proteomic Analysis of Bronchoalveolar Lavage Fluid in Asthmatics following Segmental Antigen Challenge.
J. Wu, M. Kobayashi, E. A. Sousa, W. Liu, J. Cai, S. J. Goldman, A. J. Dorner, S. J. Projan, M. S. Kavuru, Y. Qiu, et al. (2005)
Mol. Cell. Proteomics
4, 1251-1264
|Abstract »|Full Text »|PDF »
The cytokine activity of HMGB1.
H. Yang, H. Wang, C. J. Czura, and K. J. Tracey (2005)
J. Leukoc. Biol.
78, 1-8
|Abstract »|Full Text »|PDF »
Specific Interference of Urokinase-type Plasminogen Activator Receptor and Matrix Metalloproteinase-9 Gene Expression Induced by Double-stranded RNA Results in Decreased Invasion, Tumor Growth, and Angiogenesis in Gliomas.
S. S. Lakka, C. S. Gondi, D. H. Dinh, W. C. Olivero, M. Gujrati, V. H. Rao, C. Sioka, and J. S. Rao (2005)
J. Biol. Chem.
280, 21882-21892
|Abstract »|Full Text »|PDF »
The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion.
A. Tsung, R. Sahai, H. Tanaka, A. Nakao, M. P. Fink, M. T. Lotze, H. Yang, J. Li, K. J. Tracey, D. A. Geller, et al. (2005)
J. Exp. Med.
201, 1135-1143
|Abstract »|Full Text »|PDF »
Angiogenetic Signaling through Hypoxia: HMGB1: An Angiogenetic Switch Molecule.
C. Schlueter, H. Weber, B. Meyer, P. Rogalla, K. Roser, S. Hauke, and J. Bullerdiek (2005)
Am. J. Pathol.
166, 1259-1263
|Abstract »|Full Text »|PDF »
Colon Cancer Cell-Derived High Mobility Group 1/Amphoterin Induces Growth Inhibition and Apoptosis in Macrophages.
H. Kuniyasu, S. Yano, T. Sasaki, T. Sasahira, S. Sone, and H. Ohmori (2005)
Am. J. Pathol.
166, 751-760
|Abstract »|Full Text »|PDF »
Contributions of High Mobility Group Box Protein in Experimental and Clinical Acute Lung Injury.
H. Ueno, T. Matsuda, S. Hashimoto, F. Amaya, Y. Kitamura, M. Tanaka, A. Kobayashi, I. Maruyama, S. Yamada, N. Hasegawa, et al. (2004)
Am. J. Respir. Crit. Care Med.
170, 1310-1316
|Abstract »|Full Text »|PDF »
Increased Expression of the DNA-Binding Cytokine HMGB1 in Human Atherosclerotic Lesions: Role of Activated Macrophages and Cytokines.
N. Kalinina, A. Agrotis, Y. Antropova, G. DiVitto, P. Kanellakis, G. Kostolias, O. Ilyinskaya, E. Tararak, and A. Bobik (2004)
Arterioscler. Thromb. Vasc. Biol.
24, 2320-2325
|Abstract »|Full Text »|PDF »
Regulation of monocyte migration by amphoterin (HMGB1).
A. Rouhiainen, J. Kuja-Panula, E. Wilkman, J. Pakkanen, J. Stenfors, R. K. Tuominen, M. Lepantalo, O. Carpen, J. Parkkinen, and H. Rauvala (2004)
Blood
104, 1174-1182
|Abstract »|Full Text »|PDF »
The Low Density Lipoprotein Receptor-related Protein Is a Motogenic Receptor for Plasminogen Activator Inhibitor-1.
B. Degryse, J. G. Neels, R.-P. Czekay, K. Aertgeerts, Y.-i. Kamikubo, and D. J. Loskutoff (2004)
J. Biol. Chem.
279, 22595-22604
|Abstract »|Full Text »|PDF »
Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation.
R. Palumbo, M. Sampaolesi, F. De Marchis, R. Tonlorenzi, S. Colombetti, A. Mondino, G. Cossu, and M. E. Bianchi (2004)
J. Cell Biol.
164, 441-449
|Abstract »|Full Text »|PDF »
The mechanism of cell death during West Nile virus infection is dependent on initial infectious dose.
Activation of gene expression in human neutrophils by high mobility group box 1 protein.
J. S. Park, J. Arcaroli, H.-K. Yum, H. Yang, H. Wang, K.-Y. Yang, K.-H. Choe, D. Strassheim, T. M. Pitts, K. J. Tracey, et al. (2003)
Am J Physiol Cell Physiol
284, C870-C879
|Abstract »|Full Text »|PDF »
IFN-{gamma} Induces High Mobility Group Box 1 Protein Release Partly Through a TNF-Dependent Mechanism.
B. Rendon-Mitchell, M. Ochani, J. Li, J. Han, H. Wang, H. Yang, S. Susarla, C. Czura, R. A. Mitchell, G. Chen, et al. (2003)
J. Immunol.
170, 3890-3897
|Abstract »|Full Text »|PDF »
Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells.
C. Fiuza, M. Bustin, S. Talwar, M. Tropea, E. Gerstenberger, J. H. Shelhamer, and A. F. Suffredini (2003)
Blood
101, 2652-2660
|Abstract »|Full Text »|PDF »
HMGB1 as a cytokine and therapeutic target.
Huan Yang, Haichao Wang, C. J. Czura, and K. J. Tracey (2002)
Innate Immunity
8, 469-472
|Abstract »|PDF »
HMGB1 as a DNA-binding cytokine.
U. Andersson, H. Erlandsson-Harris, H. Yang, and K. J. Tracey (2002)
J. Leukoc. Biol.
72, 1084-1091
|Abstract »|Full Text »|PDF »
HMGB1 Interacts with Many Apparently Unrelated Proteins by Recognizing Short Amino Acid Sequences.